Navigation Links
Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007
Date:2/11/2008

business. The overall MLR declined 50 basis points during 2007, to 87.1 percent. The decrease was the result of significant improvements in the Commercial MLR, and relatively stable Reform MLR, offset by an increase in the Medicare Advantage MLR.

Operating expenses declined by $8.4 million, or 5.4 percent, to $148.1 million, compared with last year. The decrease is primarily attributed to lower direct costs in the Reform business resulting from the reduction in volume. The segment's operating expense ratio fell by 30 basis points, to 11.2 percent.

Three months ended Dec 31, 12 months ended Dec 31,

Managed Care

Additional Data 2007 2006 2007 2006

Member months

enrollment

Commercial

Fully-insured 1,240,630 1,277,461 4,983,980 5,272,987

Self-funded 483,563 474,492 1,930,850 1,861,833

Total

commercial 1,724,193 1,751,953 6,914,830 7,134,820

Reform 1,062,702 1,272,737 4,262,248 6,484,270

Medicare 146,365 134,429 554,040 461,718

Total member

months 2,933,260 3,159,119 11,731,118 14,080,808

Medical loss ratio 85.2% 85.4% 87.1% 87.6%

Operating expense

ratio 12.0% 13.4% 11.2% 11.5%

Managed Care As of December 31,

Membership by Segment 2007 2006

Members

Commercial

Fully-insured 412,663 423,442

Self-funded 161,588 157,408

Total commercial 574,251 580,850

Reform 353,694 357,515

Medicare
'/>"/>

SOURCE Triple-S Management Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Triple-S Management Corporation Announces Full Exercise of Underwriters Over-Allotment Option
2. Triple-S Management Corporation to Present at UBS Global Healthcare Conference
3. Case Management Cost-Effective Way to Cut Heart Risks
4. S.C. BlueCross to Integrate Care Management with Personal Health Record in Real Time
5. Marlabs in the Top 10 BPO Healthcare Revenue Cycle Management Companies
6. Painless Hemorrhoid Treatment Adds Management Punch
7. HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming
8. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
9. Standard Management Announces OTCBB Listing
10. MDS Pharma Services Wins Award for Management of Global Malaria Trial
11. AWT Management Announce Aggressive Growth and Acquisition Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Penn talks at ASCB touch on cancer, neurodegenerative diseases, and MD 2Health News:Leading Epilepsy Groups Unveil New Survey Results Challenging Patients to Take Charge of Their Health 2Health News:Leading Epilepsy Groups Unveil New Survey Results Challenging Patients to Take Charge of Their Health 3Health News:Leading Epilepsy Groups Unveil New Survey Results Challenging Patients to Take Charge of Their Health 4Health News:New Study Links Animal Agriculture to More Than 20% of MRSA Infections in the Netherlands 2Health News:Neuro Kinetics Appoints Dr. Terri Ives Clinical Director, Audiology 2Health News:Child mental health experts issue psychiatric medication treatment guidelines for preschoolers 2Health News:Child mental health experts issue psychiatric medication treatment guidelines for preschoolers 3Health News:Aerosol launches immune response in lungs to wipe out lethal infections 2Health News:Aerosol launches immune response in lungs to wipe out lethal infections 3
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8Emission capture study funded for paper industry 10353 1Emission capture study funded for paper industry 10353 2Emission capture study funded for paper industry 10353 3Fear of being laughed at crosses cultural boundaries 10348 1Fear of being laughed at crosses cultural boundaries 10348 2Fear of being laughed at crosses cultural boundaries 10348 3Fear of being laughed at crosses cultural boundaries 10348 4Webcast Alert 3A Usinas Siderurgicas de Minas Gerais S A USIMINAS Announces Third Quarter 2009 Results Webcast 59442 1Webcast Alert 3A Usinas Siderurgicas de Minas Gerais S A USIMINAS Announces Third Quarter 2009 Results Webcast 59442 2